penumbrainc Profile Banner
Penumbra, Inc. Profile
Penumbra, Inc.

@penumbrainc

Followers
4K
Following
110
Media
491
Statuses
862

Penumbra, Inc. is a global healthcare company focused on innovative therapies that address challenging medical conditions & unmet needs. https://t.co/xRiyE2RKcz

Alameda, CA
Joined February 2017
Don't wanna be here? Send us removal request.
@penumbrainc
Penumbra, Inc.
5 days
Introducing Penumbra's latest innovation, #SwiftSET Coil — expanding the procedural capabilities of the Swift Coil System. Read more here: https://t.co/1Z44Uo1LVr.
0
0
1
@penumbrainc
Penumbra, Inc.
10 days
🩺Penumbra and @isth launched a new Thrombosis Management Toolkit, offering resources for both healthcare professionals and patients including essential info on managing thrombosis and more! Read more here: https://t.co/mqJRQ2nlVN #VTEcare #WorldThrombosisDay #PatientEducation
Tweet card summary image
worldthrombosisday.org
Chapel Hill, N.C., United States, September 17, 2025 — The World Thrombosis Day campaign, led by the International Society on Thrombosis and Haemostasis (ISTH), together with Penumbra, Inc., today...
@thrombosisday
World Thrombosis Day
26 days
📥New resource just in time for #WorldPatientSafetyDay! Explore our Thrombosis Management Options guide. This downloadable resource—supported by Penumbra—offers practical insights and evidence-based info for thrombosis management. 👉 https://t.co/W8K9ibSXr8
1
4
7
@penumbrainc
Penumbra, Inc.
10 days
US HCPs: Our recent article in @EVToday explores the four Science-Based Aspiration (S-BAT) principles that guide safe and effective neuro thrombectomy. Read more here: https://t.co/Eucs4mqo1k Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary. #SBAT #Innovation
0
0
1
@penumbrainc
Penumbra, Inc.
10 days
Visit Penumbra at BOOTH #D4 during VSICON 2025 to explore our latest CAVT Technology.
0
0
0
@penumbrainc
Penumbra, Inc.
11 days
US HCPs: New data from research led by @alex_spiotta reports BMX®81 use in TRA with fewer access-site complications and similar efficacy metrics vs. TFA. Read more here: https://t.co/69u3RT0KEZ Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary
0
0
1
@penumbrainc
Penumbra, Inc.
12 days
US HCPs: New data shows CAVT technology leads to shorter hospital stays & higher rates of discharge to home for patients w/ lower extremity venous thrombus 🏥📉. Read more here: https://t.co/dHYIBuHtdV Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary
0
1
3
@penumbrainc
Penumbra, Inc.
14 days
US HCPs: On #WorldHeartDay, we’re reminded of the urgent need for rapid response in cardiac emergencies. Read how CAT RX delivered safe thrombus removal in a cardiac arrest case: https://t.co/qpyUpitwKT Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary.
0
0
0
@penumbrainc
Penumbra, Inc.
18 days
This #WorldLungDay, watch the story of Amelia who suffered a life-threatening pulmonary embolism and how #CAVT helped her return home quickly and get back to her normal routine: https://t.co/8V8ji2m6ih #LeadWithCAVT #MedTech #MedDevice #Innovation #PatientStory #PE
0
0
1
@penumbrainc
Penumbra, Inc.
20 days
🧠 Did you know nearly 1 in 50 people in the U.S. have an unruptured brain aneurysm? Lifestyle choices like not smoking, limiting alcohol, & managing blood pressure can help lower risk. Learn more: https://t.co/6KN6bWZ1sY #BrainAneurysmAwarenessMonth
0
0
0
@penumbrainc
Penumbra, Inc.
20 days
US HCPs: New research in Interventional Neuroradiology highlights the Penumbra SwiftPAC™ coil as a versatile and reliable tool designed for vessel occlusion: https://t.co/lsCxh3Qt2i Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary. #NeuroIntervention #MedDevice
0
1
4
@penumbrainc
Penumbra, Inc.
24 days
"The goal is not perfection but perfusion.” – @kavaliIR We were privileged to host A/Prof. Kavali in Singapore, where he shared valuable clinical insights on #CAVT with nearly 50 HCPs. Our sincere thanks to all who attended. #PulmonaryEmbolism #VTE #PenumbraAPAC
0
2
8
@penumbrainc
Penumbra, Inc.
25 days
#GetOutTheClot's recent survey in collaboration w/ @isth, @StopTheClot, @SVM_tweets, @VenousForum & @PERTConsortium found that only 35% of survey participants perceive the ultimate treatment decisions for VTE care are made by consensus among specialties: https://t.co/ouTmrGc8yg.
0
1
2
@penumbrainc
Penumbra, Inc.
26 days
"The goal is not perfection but perfusion.” – A/Prof. Pavan Kavali. We were privileged to host A/Prof. Kavali in Singapore, where he shared valuable clinical insights on #CAVT with nearly 50 HCPs. Our sincere thanks to all who attended. #PulmonaryEmbolism #VTE #PenumbraAPAC
0
1
8
@PenVascular
Penumbra Vascular
1 month
US HCPs: Data shows restoration of flow and improvement of symptoms after use of #LightningFlash 2.0 as the frontline device for venous management. Read more here: https://t.co/7qJnE8myqR #LeadWithCAVT Rx only. Risk: https://t.co/fL1sUmgmEd results may vary
0
1
5
@PenVascular
Penumbra Vascular
1 month
US HCPs: NOW introducing Lightning Bolt 6X with TraX in 150 cm length. Read more on the newest addition to your complete CAVT platform for the management of arterial thrombus: https://t.co/IAw1eq5wMy #CAVTforBTK Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary
0
4
10
@penumbrainc
Penumbra, Inc.
1 month
📊 Get Out the Clot announces a recent survey which reveals more than 50% of physicians report no formal response team for #PE care at their institution. Learn more about these results here: https://t.co/ouTmrGc8yg #VTEcare #PatientCare #GetOutTheClot
0
1
3
@penumbrainc
Penumbra, Inc.
1 month
September is #BrainAneurysmAwarenessMonth. A #BrainAneurysm is a bulge in a weakened brain artery. If it ruptures, it can lead to life-threatening conditions. Prevalent in ages 35-50 but early detection can save lives, learn more: https://t.co/h02HFH7qIY
0
1
3
@penumbrainc
Penumbra, Inc.
2 months
From would-be wildlife photographer to systems analyst, learn how Kyle McBard’s journey reflects a lifelong love of learning & exploration: https://t.co/hvCIfUvUQs. To learn more about career opportunities, visit: https://t.co/S6Kq5XGi5M #PenumbraProud
0
0
2
@PenVascular
Penumbra Vascular
2 months
US HCPs: Research indicates high rates of venous rethrombosis with basket technologies and low rates of VTE-related readmission with CAVT. #VeinHealthMatters #LeadWithCAVT Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary
0
3
11
@penumbrainc
Penumbra, Inc.
2 months
Today, Shruthi Narayan was promoted to President of Penumbra. “Penumbra has been at the forefront of blood clot care for more than 20 years… I am honored to carry on and expand our legacy of innovation,” — Shruthi Narayan Read more here: https://t.co/0TQXGiSDcb
10
5
48